chison medical imaging co. ltd. 510(k) submissochison medical imaging co., ltd. 510(k) submission...
TRANSCRIPT
JUN 0'22014 pay-~ 4Chison Medical Imaging Co. Ltd. 510(K) Submisso
510(k) Summary
This Summary of 510 (K) Safety and Effectiveness information is being submitted in accordance withthe requirements of SMVDA 1990 and 21 CFR Part 807.92.
The assigned 510(K) number: K140364
1. Date of submission : January 12, 2014
2. Submitter:Chison Medical Imaging Co., Ltd.No.8, Xiang Nan Road, Shuo Fang, New District, Wuxi, China 214142
Contact: Ms. Ruoli MoTel1: +86-510-85311707, 85310593 Fax: +86-510-85310726U.S. Agent: Leiker Regulatory & Quality Consulting
7263 Cronin CircleDublin, CA 94568
Contact: Bob LeikerTel: (925) 719-1946 Fax: (866) 718-3819
3. Proposed Device Identification:Trade/Proprietary: Q Series & i7,i8, i9 Diagnostic Ultrasound System
Common Name: Diagnostic Ultrasound System with Accessories
Classification: Regulatory Class: 11Review Category: Tier 11
Classfication Name 21 CFR Section Product CodeUltrasonic pulsed dloppler imaging system 892.1550 90S-IYNUltrasonic pulsed echo imaging system 892.1560 90-IYGDiagnostic ultrasonic transducer 892.1570 90-ITX
4. Legally Marketed Predicate Device:K1 01236, GE Voluson E6/E8 /E8 Expert Diagnostic Ultrasound SystemK120801 CHISON iVis6OEXPERT, Q6/Q8, i7 Diagnostic Ultrasound Systems
5. Device Description:
510(k) Summary Page 1 of 11
Chison Medical Imaging Co., Ltd. 510(K) Submission
The Q6IQ8IQ9IQ1O/i7/i8 /i9 ultrasound system is an integrated preprogrammed color dopplerultrasound imaging system, capable of producing high detail resolution intended for clinicaldiagnostic imaging applications.The CHISON ultrasound system can be configured either as a portable model (Q6IQB/Q9IQ1O),or as a roll-around model on wheels (i7/iBi9). These systems are designed with the latesttechnology, using the same quality procedure as ultrasound systems which have been availablein the market for years.
This CHISON ultrasound system is a general purpose, software control led, diagnostic ultrasound*system. Its basic function is to acquire ultrasound echo data and display the image in B-Mode(including Tissue Harmonic Imaging), M-Mode, Pulsed (PW) Doppler Mode, Continuous (CW)Doppler Mode, Color Doppler Mode, Power Doppler Mode, Directional Power Doppler Mode, TDIMode or a combination of these modes.3D/4D.
6. Indications for Use:The device is a general-purpose ultrasonic imaging instrument intended for use by a qualifiedphysician for evaluation of Fetal/OB3; Abdominal (GYN & Urology); Pediatric; Small Organ(breast,testes, thyroid); Neonatal Cephalic; Adult Cephalic; Cardiac (adult & pediatric); PeripheralVascular, Musculo-skeletal Conventional & Superficial, Transvaginal.
7. Summary of Modifications and Newly Added FeaturesThe Q Series & 7, i8, i9 Diagnostic Ultrasound System employs the same technology as thepredicate devices. This submission device is a modification to CHISON iVis6OEXPERT,Q6 /Q8,7 Diagnostic Ultrasound Systems previously cleared in K(120801. The submission device alsohas the same intended uses and basic operating modes as the predicate devices.The following is a brief overview of the modifications and newly added features. Detailedinformation is found in Section 1_-4 General Device Description of this submission, while Section1 5 Predicate Device Comparison to Legally Marketed Device includes a discussion ofsubstantial equivalence with the predicate device(s).Newly added transducers:D3C6OL-BDSC6OL-CD7L4OL-CD12L4OLD7C1 0[-CV6C1OLD5C2OL-AD3C2OL
D6C1 5L-AD2D16L
510(k) Summary Page 2 of 11
Chison Medical Imaging Co., Ltd. 510(K) Submission
V4C4OL-CNewly added software options:2D SteerElastographyCurved Panoramic ImagingSupper needleIMT Auto IMT measurementvascular measurement packagesmall parts measurement packagePediatric measurement packageAll of the above modifications have been compared with the predicate devices. The results showthat these modifications are substantially equivalent to the predicate devices.
8. Testing:Laboratory testing was conducted to verify that the 530 system with added transducer met all
design specification and was substantially equivalent to the Predicate Device.The device has been found to conform to applicable medical device safety standards in regardsto thermal, mechanical and electrical safety as well as biocompatibility.lEG 60601-1: 2005 Medical Electrical Equipment - Part 1: General Requirements for SafetylEG 60601-1 -2: 2007 Medical Electrical Equipment - Padt 1-2: General Requirements for Safety -Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests.lEG 60601-2-37: 2007 Medical electrical equipment - Part 2-37: Particular requirements for thebasic safety and essential performance of ultrasonic medical diagnostic and monitoringequipment.NEMA UID 2-2004, Acoustic Output Measurement Standard for Diagnostic Ultrasound EquipmentVersion 3.NEMA UD3: 2004 Standards for Real-time Display of Thermal and Mechanical Acoustic OutputIndices on Diagnostic Ultrasound EquipmentISO 10993-1: Biological evaluation of medical devices -- Part 1: Evaluation and testing within arisk management process
9. Clinical Test:No clinical testing was required.
10. Comparison to Predicate Device:
Table 1 Substantial Equivalence Comparison
51 0(k) Summary Page 3 of 11
W U)
ci Uo
62 ~ ~ 0 0): c T
(D o C a)0a)(
r, *-C n -'D Cm aa) 150 UvOC c uiup -
CL M~8L 5 .a, -J ) W "C
o~ 0)050'
W (n 0Co M CC QV~ ) r~ )rE
in fl . ) 2ca L) a)L0c
) co -u 00u CD - )A
oU ) 0 0 -o0 CL
a) a )
.=ft>
0 V.5 0) -(Ouo co 0" Q C 0>, 0=
TL L < 0- 0 )2* w a- Co- to Ba,)
o~ 0)-
o~c 0.5 ccta LL 0)0 rw -_
to - D CL)0 ECLo-a 0- Z 0 0) 002L a ~ .o~~a~ w m' 300)0 - - (
w 00 - >, = - cC-C D 2 60r6 20Lu w' m .9v 5' - Z _E
(o , " -co(a Do - 0 0 )) E
CD Q) 0 C A > 00w- < D-C5 U) (,
a) ~ow~ co a a. 0u OW > /M 7v 0 Z.w LEtL) CL o
L** 0
o U)o 0) (DE
-ffia.CL.- 0-. S2 - C ;--zc c, -5 a C0
a) __ __ _ _ _ _ __ _ _ _ _ w__a)_ _____0____MIo
w ) < D U) <) < a) ) ) a) )
U ) U) U) U U)U) U)( ) Q
I-~C a) U) U u V
CL~C c)m) C? C 0
-n,~~~~C C.0Ucc)D aa) 00m 0 m -
a5 m) cN 0)
-) .2 a . ,o ~ U) )
.2 0)~ 0 di(
"0a E -- H u Dwo a cc C) CL o:
". =j a 2 t5 WH -aa~C0 c ) r Q
O ) 0 LU" L10 M CO LL IL < ) U) < 0
C)IC) w C
00 Q)- 0 0 in
0 0a ~ 'n r4a CL Fn- 0- *.+ m ')Co U) L mE-TN m
CY~~ ~ ~ ~ nUCD~ 'cc I L00E0t-) flQ5 ) m 0
t5C -a~ -) Cw~f xN T 0-
0) a).-JJ o, a )Q 0 E C
as ) C0)0- U)~. U) L
x C) CLa cC
, a))) 0 E- a- a
2U CD W a mn o m a0 0 0a) ( : L) CL a) a)
-T 0) 0 U) a 5 )aWX L to % go +1 Ca)~ ~ C7a ) 0U
"LU~ ~ om v'U- 0c am c 0oD E CL ) 0 . VH~
C~$~C C U , a_ 0 2) c"I cJC))O C U)
C)a m C
V -I-a) C) L- 0
L.N t0 CL 0O aw '9g c
_) C- _ lQ . L Q
- w c) 0za
> ~ cc -E0c~ 0
2u 0 4 c mLO- L0 L00 a)-V5 ) 3: 0 U 75
a) C) 0E EE E
m co
a - o -. ( 0McE 0 u (Nt
soC tooc,
) J7 3 0 o - 1-0 C,
Bo U E o ~ E gE a) :Oof mE a) 00EcO-. t F
E a)E 2 E) c, a.
c~ g >"
CL CL CL0 . ,c,E I
cC?
000 M a)~ 0=
ccC O O ao , a 0 ) a) .
W0 Ei- ( RC o E- 2 o E'a). C ~cu 'Qosa 0a j3(
, ~ ~ ~ ~ t Z ? SO> E C
CODE r0 0 0
D o. (D
0) 2~ Vu S00 0
C-0 -~ g2w-- - )0--
-c, 0: g2 0 t v
a) w -t Zn'' C
E >a
cu ~ ~ ~ cv2C)u m 0 >5 F- >a)
iv c t u a) - aa ) a ) -- C
m CeCL W 04 M c
cuo - .Q ) LC(O S co( 02 L -
-- c 0
)A a >Lu_ _ - , , _ _ _ _ _ o_ _ _ __D_'aIs
EE E E
0)0- a)_ QS) 3:73--
a) E C l a -8C S
0 02 -a 0
.23 o a - a)- L)za
0) co X a) W3 Lft0 LL - o nb(OD O2
E0 CO> EC>3: 0. 2: 2 m . c 0, 0-C-
.0 a)) OO O cl V a-- 0D .- 4-- 0 0c LLW m" >;LC> U > 00 )0 0 0 000 L . 0 E D
0.
a 00 0) 0L . 9 D Q)a a) 000
Etoao v3 00~cZ 5o 2 -' a-0- La), - a
CL) L) ~a) Cwo .2 ) oa)c 0 2
0 a)n a0) 0 130 .a
coa LC La Q 0) 75 00
-J ): 2 0 m- ov0 0L oL Qa202
22U~ a' L 0a) F
*6c =-n CDEa~ 2 CLw :E ) 0 ) 0 0 LLcD 0 > E -5M U 0 Q 0 )Ha
CL U) 0 j >W 0 0--C C)n. o E -0 -
Z x. 0m 0L a 0 c- ++.< c Eo1
w >C- ~Q u0 ~ 0 aO) 022
0 C co-E caoC-) L00(D' .2 Q~ 00z~~ oo -2a) ggg cUL CL CL C
CL - c a)L) 2 ~ uF u2c a 'i<I
00E ZO j -L 0 u 00a- o
-2
E EEm w
_ _ _ Cl L)
a) EIO OWL 2 Ea)a
- f 0~ (Dt E 0 0mN 0 E .0O C C a- ME5 >n~j
ow-a E0 0 O w ~ & ~ £
Q) a)aL
a) EE-.2 2 0~ a )E
Ct CL o C 3 w 0 -.. ,- a-0 0n Z2 <na a
Eo.2 Egc - E6 c -r mIwL cuE2 oz EQ[2E E03LU
U) ~~ 25& cl Of 2mm(P- ot~1 fl z o3 w fl) cyG)
-n( 0) - -0
E 03 C)3 00 3-L Jc; L
I a)b~' - a )-a o (co' (' LA0,Nf a Z0
o3 ca 0 e02-w -M- o c w o o 0 c b
-0 c -(C ~ L-7 a)- .
co a) W 00 w03 C -5L)OWW >, n W i6 o aco aL
-CL% 0 ~ w~ C z O(D
Q) 0 U -0).02 - 0-0) 0m0
zn 0 >.0 2 D O rjL-E E ?E=
= 0-( aa M 4m . u7 10(
n_ , -mt.
C,)
cc
cu < a) a) a)EE E E E
_ _(2 Co -cc (D2 0/
o DM ) a a)t- W oE Z fl CLm -00wm
oc o U) mU z 0) E- a) P
a) 0 0 V) 75 ()(/a) C aCL '
CL >-~ U)M 1)o>
2) 0 C)WEVt Eu 0 *-l) 00l -- oraC cuaw
D > a ---au -- CL)Ct5 cjZ0 0M
'm qr2F 0D0 I>tC o0 mm a)Co)a)M 4- o c.7 -V a C- >' WOW!E < .o~ (mE E, tn jc "00 c )
ao 0 c a2w a) CLH - 0-a6 >U C) CD < -~ m CC
2 ~ 02<5iZ~ ) x-M OL or0)o c*Nw-UEj'AZ~~ Q)l)S 0. E a tCD j CJ Q 0 ... L
a) -0 0~ o1 C. o acn I.-tEacC> 0v< aXa)
00oJ a
E - C -a,=.CLL.a
CL- ~ ~ DL >- / )L )o0 0PC) a 0)a a)aa
XCUo 0 C) E
mf > maL f) ::, a)a~C "DDW C,3'&
o QW C)(C QLJ .- 65 ) *OC)<a_ 0- QW
~a) WC..rn ( .5 tcO) EH
.- Qr C)-o Em >U )00 pto 04cL 0C> 0 ~ 0 ).0
CC: Lo Ln ji -d 2 U0 ,) o d a) m o w
Ln 0 2 E
0 Pa <iC 00 C/
a. - u 0 D CL D
E < Q)ELU mU) U)
C 0) CDCLX CL ccfn
W 0-0-C(0
> CU cu C ZN: 50 C:, CD 0c x E > 6 cL - w 0M cu a) CD cS E E E -ob = E i= 'T cu = 0 c>0 0 C
E 7) 0) E 2 E 10V) >L) (U C) cE E E aD) mLOs-< .F (U
Cl) <CO 0) 0 (u CL 6 a)
0 E - m < L'L 0 c5m a0 0 0 0 00 cc a)IT 70
CL CD co m > 0X CL CL U) d) U)co Q)
0 06 E E
CC, N < 4) a) (DJ]f - < 0c (DE > c w > 6.= >LLI E 6 E E a) CL 0 a) CLcl 0 " Lo 0 6 m 0 d-pm
r, LL > U-) LL > > U)z CD ff ff E Z)0 0 00 CD co E (D .0 Lo M CL.T a) D- a) - 0)U) (D o E 0 - = 0 .- z (D -0
U) C'A 5< cu CY 3: z -0 M CL CT m = E , [ : < 0 nao U L2 cL m C1 0 -j E i E o IL COL) e E L 0 & c:) 0 co < 0 EL L U)
>0 C)0 0L) 0 L)ECU 0C) -0E > +I C? "a a)
E a) x LO - 00 Co 0 -0 <tm M . - m
'r E N E 00 a) LLC 00) x C > to >u LL) Co0) a) N 0 >
W E >cD E o a)00 LO 0CL E c)LU r- 3:
to Co CD _:'DC-)m Cl) CD c X0 m C 'a
M a) ID Co > go U)CD 0 a) E < C6 ll0 U) a) 0 CU CLZ (D (D 'E
ILI> e P-- 2 LL o C-L CL > 0 o
Em w EZ E (D 0 EE cn DL) o (tun
o CY 4)0 (L0:
Chison Medical Imaging Co.. Ltd. 510(K) Submission
Comparison Analysis
SE Analysis 1The Operating Controls item of proposed device and the predicate deviceare with different Image Reverse/Frequency Selection/AngleCorrection/Steered Linear/Color Maps/PD Color Maps, but they can beconsidered Substantially Equivalent in safety and effectiveness. So the SEis not affected.
SE Analysis 2The screen size of the proposed is smaller than that of the ES. Thisdifference is considered to have no effect on effectiveness and safety.
SE Analysis 3The Transducer Connectors of the proposed is less than that of the E8. Thisdifference is considered to have no effect on effectiveness and safety.
SE Analysis 4The Power Supply of the proposed device and the predicate device are AC:1bOy- 240V and AC: 220V - 240V; 100OV, 11 5V- 130 V respectively, but both ofthem comply with IEC60601-1 and IEC 60601-1-2. Therefore, power supplycan be considered Substantially Equivalent in safety and effectiveness.
Discussion of Substantially EquivalentThe subject device has same intended use, same product design, sameperformance effectiveness, and performance safety as the predicatedevice. The differences above between the subject device and predicatedevice do not affect the basic design principle, usage, effectiveness andsafety of the subject device.
11. Substantially Equivalent Conclusion:I n accordance with the Federal Food Drug and Cosmetic Act. 21 CERPart 807 and based on the information provided in this premarketnotification, Chison Medical Imaging Co., Ltd. concludes that theCHISON Q Series and i7, i8, i9 Diagnostic Ultrasound System issubstantially equivalent to predicate devices with regard to safety andeffectiveness.
510(k) Summary Page 11 of 11
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
.4 10903 New Hampshire Avenuec
June 2, 2014Chison Medical Imaging Co., Ltd.% Mr. Bob LeikerLeiker Regulatory & Quality7263 Cronin CircleDUBLIN CA 94568
Re: K140364Trade/Device Name: Q Series & i7, i8, i9 Diagnostic Ultrasound SystemRegulation Number: 21 CER 892.1550Regulation Name: Ultrasonic pulsed doppler imaging systemRegulatory Class: 11Product Code: IYN, IYO, ITXDated: April 15, 2014Received: April IS, 2014
Dear Mr. Leiker:
We have reviewed your Section 5 10(k) premarket notification of intent to market the devicereferenced above and have determined the device is substantially equivalent (for the indicationsfor use stated in the enclosure) to legally marketed predicate devices marketed in interstatecommerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or todevices that have been reclassified in accordance with the provisions of the Federal Food, Drug,and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).You may, therefore, market the device, subject to the general controls provisions of the Act. Thegeneral controls provisions of the Act include requirements for annual registration, listing ofdevices, good manufacturing practice, labeling, and prohibitions against misbranding andadulteration. Please note: CDRH does not evaluate information related to contract liabilitywarranties. We remind you, however, that device labeling must be truthful and not misleading.
This determination of substantial equivalence applies to the following transducers intended foruse with the Q Series & i7, i8, i9 Diagnostic Ultrasound System, as described in your premarketnotification:
Transducer Model Number
D3C6OL, Convex Array D3C6OL-B, Convex ArrayD3C6OL-C, Convex Array D7L4OL, Linear ArrayD7L4OL-C, Linear Array D7L6OL, Linear ArrayD I2L4OL, Linear Array D7L3OL, Linear ArrayD6CI2L, Micro Convex Array D7C IOL, Micro Convex ArrayD7C IOL-C, Micro Convex Array V6C IOL, Volume ProbeDSC2OL, Micro Convex Array D5C2OL-A, Micro Convex ArrayD3C2OL, Micro Convex Array D6CIS5L, Micro Convex ArrayD6CISL-A, Micro Convex Array D3P64L, Phased Array
Page 2-Mr. Leiker
D6P64L, Phased Array D2DI6L, Pencil ArrayV4C4OL, Volume probe V4C4OL-C, Volume Probe
If your device is classified (see above) into either class!!1 (Special Controls) or class III (PMA),it may be subject to additional controls. Existing major regulations affecting your device can befound in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA maypublish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not meanthat FDA has made a determination that your device complies with other requirements of the Actor any Federal statutes and regulations administered by other Federal agencies. You mustcomply with all the Act's requirements, including, but not limited to: registration and listing (21CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medicaldevice-related adverse events) (21I CFR 803); good manufacturing practice requirements as setforth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronicproduct radiation control provisions (Sections 53 1-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), pleasecontact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041or (301) 796-7100 or at its Internet addresshttp)://www.fda.gov/Medical Devices/ResourcesforYou/Industrv/default.htm. Also, please notethe regulation entitled, "Misbranding by reference to premarket notification" (2ICFR Part807.97). For questions regarding the reporting of adverse events under the MDR regulation (2 ICFR Part 803), please go tohttp://www.fda.gov/MedicalDevices/Saft/ReportaProblem/default.html for the CDRH's Officeof Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from theDivision of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301)796-7100 or at its Internet addresshttr)://www.fdasgov/Medica] Devices[ResourcesforYou/lndustrv/default.htm.
Sincerely yours,
forJanine M. MorrisDirectorDivision of Radiological HealthOffice of In Vitro Diagnostics
and Radiological HealthCenter for Devices and Radiological Health
Enclosure
510(k) Number (if known)
K140364
Device NameQ Series & i7, iS, i9 Diagnostic Ultrasound Systems
Indications for Use (Describe)The device is a general-purpose ultrasonic imaging instument intended for use by a qualified physician for evaluation ofrretal/OB:Abdomninal (GYN & Urology); Pediatric; Small Organ (breast, testes, thyroid): Cardiac (adult & pediatric); Peripheral Vascular,Musculo-skeletal Conventional & Superficial, Tranisvginal.
Type of Use (Select one or both. as applicable)
SPrescription Use (Part 21 CFR 801 Subpart 0) E0 Over-The-Countier Use (21 CFR 801 Subpart C)
PLEASE DO. NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signatures)
FORM FDA 3881 (1114) Pop, 1 of 24 Ia.Swioui H
Chison Medical Imaging Co.. Lid. C Series & V?. ill, i9 Diagnostic Ultrasound Systems
Diagnostic Ultrasound Indications For Use
System: Q6/08/OQ 10, i7/i8/19 Diagnostic Ultrasound Systems
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode of 0peration _________
General specific B M PW CW Color Power Combined Hlarmonic Other(Track I Only) (Tracks I & 3) B M Dopple Dopi Doppler Dopple Modes Imaging
Ophthalmic Ophthalmic _________
Fetal Imaging& Fetal P P P P P P P 3,5Other Abdominal P P P P P P P 3,4,5
Intre-operative(Specify) ___ ______ ____ ____
Intra-operative (Neuro) _________
Laparoscopic __________
Pediatric P I p P P P P 4.5Small Organ"' (Specify) P p p P P p p 4.5Neonatal Cephalic ____ _____
Adult Cephalic __ _____
Truns-rectal _____ _____
Trans-vaginal p p P p p p P 3.4.5
Truns-urethral ___________
Trans-esoph. (non-Card.)Musculo-skeletal P p p p P P P 4.5(Conventional) I__________
Musculo-skeletal p Ip P p P P p 4,(Superficiali____ ____
Other (Urology) p p P p p P P 4,5
Other (Ob/GYN) P P PPPP p p 5
CricCardiac Adult P p p P P P PP 5_______Cardiac Pediatric P P p p p p ppPe ea eslPeripheral vessel P P p p P P p I p # 5q
N =new indication; P = previously cleared by FDA; E - added under this appendix
Note: :1. Combined modes are B/M. B+-PWD. B/Color M, B/PWD or CWD. 1/Color/PWD or CWD.B/Power/PWD2.Small Organ: Breast, testes, thyroid3.3 DI4D Imaging Mode4.El1astography imaging5. Includes imaging of guidance of biopsy (Super needle)
Prescription Use >( AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) -(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For Use Page 2 of 24
Chison Medical Imaging Co., Ltd. C Series & 17,1il, 1S Diagnostic Ultrasound Systems
System: Q6108/Q9/Q1O, i7/18/19 Diagnostic Ultrasound SystemsTransducer: D3C6CL, Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application ____ Mode of Operation ____ __
General Specific B M PW CW Color Power Combined Harmonic Other(Track I Only) (Tracks I & 3) 13 M Doppler 22ppr Doppler Dopplej Modes Imaging
Ophthalmic Ophthalmic _____
FetallImaging & Fetal P P P P P P P 5Other Abdominal P P P p p p p 4,5
Intira-perative(Specify)Intra-operative (Neuro)II IILaparoscopicPediatricSmall Organ" (Speify
coaa ehalicAdult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.) ___
Musculo-skeletal(Conventional) ___ - - -
Musculo-skeletal(Superficial)Other (Urology) P - - P 4.
Ot_____ her (Ob/G VN) P PP P P PP P
Cardiac Cardiac Adult ____ _____
______________Cardiac Pediatric ____ _____
[Peripheral Vessel Peripheral vessel ____ _____
N = new indication; P = previously cleared by FDA; E =added under this appendix
Note: 1. Combined modes arm BIM, B+PWD. B/Color M, B/PWD or CWD. B/ColorIPWD or CWD,B/Powcr/PWD2.Small Organ: Breast, testes, thyroid3.3D/4D Imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Seclon 1.3 Indications For Use Page 3 of 24
Chison Medical Imaging Co.. Ltd. 0 Series & 17. iW, is Diagnostic Ultrasound Systems
System: 061081Q91010, i7fi~fi9 Diagnostic Ultrasound Systems
Transducer: D3C6OLt'B, Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode oro Oeration
General Specific PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M Doppler Doppler Doppljr Doppler Modes Imaging Ote
Ophthalmic OphthalmicFetal lmaging& Petal N N N N N IN N 5Other Abdominal N N N N N N N .3
I ntra-operative(specify) ____
Intra-operative (Neuro) I____
lapaosopic _____ ________
Small Organ"'( Specify) ____
Neonatal CcphalicAdult CephalicTranis-rectal ____ ___
Trans-vaginalTrans-urethralTrans-esoph. (non-
Card.)--------------------------Musculo-skeletal(Conventional)_____
Musculo-skeletal(Superficial)Other (UrologNyN) N N N N 4.5
________Other (Ob/GYN) N I N N N N 5
CardiacCardiac Adult_____________Cardiac Pediatric
Periherl VeselPeripheral vessel ____
N =new indication; P = previously cleared by FDA: E added under this appendix
Note: 1. Combined modes arc B/M. B+PWD. B/Color M. B/l'WD or CWD. B/Color/PWD or CWD).B/Powvcr/PWD2.Small Organ: Breast, testes, thyroid3.3D/41" Imaging Mode4.Llaslogntphy imaging5. Includes imaging of guidance or' biopsy
Predicate transducer (K number); K 101236, K 120801
Prescription Use X AND/ORk Over-The-Counter Use __ _
(Part 21 CER 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH. Office of Device Evaluation (ODE)
(Division Sign Of)Division of Radiological Health
office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For Use Page 40of24
Chison Medical Imaging Co., Ltd. 0 Series & 17. i8.9i Diagnostic Ultrasound Systems
System: 06/08/09/0 10, 17/18/19 Diagnostic Ultrasound Systems
Transducer: 03C60L-C, Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of 0aeration
(Track I Only) (Tracks I & 3) B M OtheolrPwerobie aroiGeneralEpI Speifile Doppler Doppler Modes Imaging Ote
Ophthalmic Ophthalmic ___ ____
FetallImaging & Fetal N N N ___ N N N N 5Other Abdominal N N N ___ N N N N 4,5
Intra-operative(Specify) ____ ____
Intra-operative (Neuro) _____
Laparoscopic ___
PediatricSmall Organ"'l (specify) ____
Neonatal Cephalic ___ ____ ____
Adult Cephalic ____
Trants-rectalTrams-vagi nalTrans-urethralTrans-esoph. (non-Card.)
Musculo-skeletal(ConventionlMusculo-skeletal(Superficial) _________
Other (Urology) N N N N N N N 4.5_________Other (Ob/GYN) N IN N N N 5
Cardiac Card iac dut ____
_____________Cardiac Pediatric ____
Periherl Veselperipheral vessel ___________
N - new indication; P = previously cleared by FDA; E - added under this appendixNote: 1. Combined modes arc B/M, B+PWD, B/Color M. B/PWD or CWD, B/Color/PWD or CWD,B/Powvcr/PWD
2.Small Organ: Breast, testes, thyroid3.3D/4D Imaging Mode4.Elastography imaging5. Includes imaging of guidance or biopsy
Predicate transducer(K number): K101236. K4120801
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence ofCCDRHl Office of Device Evaluation (ODE)
(Division Sign Oft)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For use Page 5 of 24
Chison Medical Imaging Co., Ltd. 0 Series & 17,.18.11? Diagnostic untrsound System
System: 06/Q8/09/O i7fi8/i9 Diagnostic Ultrasound Systems
Transducer: D7L-4OL-, Linear Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of Operation _________
General Specific B ri PW CW Color power Combined HarmonicOte(Track I Only) (Iracks I & 3) Doppler Ioppler Doppler loppler Modes Imaging
Ophthalmic Ophthalmic ___ ____ _____
Petal Imaging & FetalOther Abdominal
Intra-operative(specify)Intrit-operative (Neuro)I
apamoscapicPediatric P p p p P P 4,3Small Organ"r(-S-pciiV) P P P P P P P 4.5
eonatal Cephalic ____
dult Cephalic ____ _____
runs-rectalruns-vaginal ____
Truns-urethralTrans-esoph. (non-
Card.) _ _
Musculo-skecletal p p p P, p p P 4,5(Conventional) ____
Musculo-skeletal N N N N N IN N 4.3(Superficial)Other (Urology) _____
___________Other (Ob/GYN)
Cardiac Cardiac Adult ____ _____
______________Cardiac Pediatric ____ _____
erheaVeslPeripheral vessel IP IP P p p P p5
N =new indication; P - previously cleared by FDA: E3 - added under this appendixNote: 1, Combined modes are B/M. B+PWI). B/Color M. I3/PWD or CWI). fl/Color/PWI) or CWD.B/Power/PWD
2.Small Organ; Breast, testes. thyroid3.3D/41) Imaging Mode4,Fiastography imaging5. Includes imaging of guidance of biopsy (Super needle)
Prescription Use X AND/ORk Over-The-Counter Use - -___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONITINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRHK Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For Use PageS6 of 24
Chison Medical Imaging Co.. Ltd. C Series & 17, il8. i9 Diagnostic Ultrasound Systems
System: Q6/QSIQ9IQ1O, i7/18/19 Diagnostic Ultrasound Systems
Transducer: D7L4OL-C, Linear Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of 0 peration ____
General Specific PW CW Color Power Combined Harmonic(Track I Only) (Tracks I & 3) B M Dpl ole opeDale Mds Imaging Other
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
Intra-operative(Specify) ___ ____ ____
Inut-operative (Neuro) I______ ________
La pa rosc op icPediatric N N N N N N N 4.5Small Organ"(Speciry N N N N N N N 4.5Neonatal Cephalic ____ _____
Adult Cephalic ____ _____
Trans-rectalTrans-vaginfalTrans-urethralTrans-esoph. (non-
Card.) _______
Musculo-skeletalN N NN NNN 4,(Conventional) N____ N IN IN NN N 4,
Musculo-skeletal N N IN N N N N 4.5(Superficial)Other (Urology)
__________Other (Ob/GYN) __________
Cardiac Cardiac Adult ____ _____
______________Cardiac PediatriclPeripheral Vessel Peripheral vessel N N N NIN = new indication; P - previously cleared by FDA: E - added under this appendixNote: 1. Combined modcs arc B/M, B+PWD. B/Color M. B/PWD or CWD. B/Color/PWD or CWD,B/Powcr/PWD
2.Small Organ: Breast, testes, thyroid3.3D/4D imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy (Super needle)
Predicate transducer (K number): K 10 1236. K 120801
Prescription Use X AND/ORk Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 7 of124
Chison Medical Imaging Co.. Ltd. 0 Series & 17. il. a) Diagnostic Ultrasound Systems
System: 061081091Q10, i7fi8/19 Diagnostic Uhtrasound Systems
Transducer: D7L6OL, Linear Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of 0peration
General Specific B M PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M Doppler QDopl Doppler Doppler Modes Imaging Ote
Ophthalmic Ophthalmic ___
Fetal Imaging & FetalOther Abdominal
Intrat-operative(Specify)Intm-operative (Neuro)
Pediatric p p p p p p p 4,5Small Organ"-(Specify) p p p p p p3 p 4,5Neonatal Cephalic ____ _____
Adult Cephalic ____ _____
Trans-rectal _____ _____
Trans-vaginalTrans-urethral _____
Trans-esoph. (non-Card.) _____________
Musculo-skeletal p p p p P p 45(Conventional)_____Musculo-skeletal N N N N N N N 4.5(Superficial) _________
Other (Urology) _ ______
__________Other (Ob/OYh)
kardiac Cardiac Adult ____
I_______ lCardiac Pediatric I____ ____
Pecripheral Vessel Peiripheral vessel I P p, p p P I P 5
N - new indication; P = previously cleared by FDA; E =added under this appendixNote: 1. Combined modes arc BIM, B+PWD. B/Color M. BIPWD or CWD. B/Color/PWD or CWD.B/PowcrIPWD
2.Small Organ: Breast, testes, thyroid3.3 W'$D Imaging Mode4.Elasiography imaging5. Includes imaging of guidance or biopsy (Super needle)
Prescription Use X AND/ORk Over-The-Counter Use ___
(Part 21 CERS801 Subpart D) (21 CFRB07 SubpartC)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH. Office of Device Evaluation (ODE)
(Division Sign Off)Division or Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indlcattoms For use Page 8Sof 24
Chison Medical Imaging Co., Ltd. C Series & V7, is. i9 Diagnostic Ultrasound Systems
System: 06/08/09/Q 10, W7II)1 Diagnostic Ultrasound SystemsTransducer: D1 2L-40L, Linear Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of 0penulion _________
General Specific PW CW Color Power Combined Harmonic(TakIOnly) (Tracks I & 3) B M .opeDpl ope Dpl oe mgn Other
Ophthalmic OphthalmicPetal Imaging & FetalOther Abdominal
Intra-operative(Specify) __________
Intina-operative (Neuro) _____________
LaparoscopiePediatric N N N N N N N 4.5Small Organ"T(S-pecify) IN N N N N N N 4.5Neonatal Cephalic ____ _____
Adult Cephalic ____ _____
mrns-rcial _____
Trans-vagi nalinans-urethral
Trans-esoph. (non-Card.) ____ __
Musculo-skeletal N N N N N N IN 4,5(Conventional) ____ _____
Musculo-skeletal N N N N N N N 4.5(Superficial) _________
Other (Urology) ____
__________Other (Ob/GYN) _ ______
Cardiac Cardiac Adult _____ ________
______________Cardiac Pediatric _____
lPeripheral Vessel Peripheral vessel IN N N N IN I N N 5
N = new indication; P = previously cleared by FDA: E added under this appendixNote: 1. Combined modes are 13/M. B+PWD. B/Color M. B/PWD or CWD. B/Color/P WI or CWD.B/Power/P WI
2,SmalI Organ: Breast, testes, thyroid3,3D/413 imaging Mode4.Elasiography imaging5. Includes imaging of guidance of biopsy (Super needle)
Predicate transducer (K number): K101236
Prescription Use )< AND/ORk Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For Use Page 90124
Chison Medical Imaging Co., Ltd. C Series & i7,II.1i9 Diagnostic Ultrasound Systems
System: 061Q81091010,. 1711819 Diagnostic Ultrasound SystemsTransducer: D7L-3OL. Linear Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application ____Mode of 0 eratlon _________
(T nraIOly (tr ifc I &3 PW CW Color Power Combined HarmonicGnrackIOly SpeciackI B M) Dppe~ !plr Dple Doppler Modes Imaging Other
Ophthalmic Ophthalmic ___ ____ _____
eta!l Imaging & FetalOther Abdomninal
I nti-operative(specify) ____ ____
Intra-operative (Neuro)LaparoscopicPediatricSmall Organ" 1 Specify N N N N N N N 4.5Neonatal Cephalic
Adult Cephfalic _____
Trans-rectalTrans-vagi nalTran s-u rethralITrans-esoph. (non-
Card.)Musculo-skeletal p p p p, P P P 4,5(Conventional) ____ ___
Musculo-skeletal p P P P4.(Superficial) ______ ______ __4.5
O0ther (Urology) __ __ _______
Cardiac Cardiac Adult ___ ____ ____
_____________Cardiac Pediatric _____________
epheral Vessel Peripheral vessel IN N N [Nih N IN N # :::N = new indication; P = previously cleared by FDA: Em= added under this appendixNote: 1. Combined modes are B/M. B+PWD. B/Color M. B/PWD or CWD. B/Color/PWD or CWD.B/ower/PWD
2.Small Organ: Breast. testes, thyroid3.31)141 Imaging Mode4.F.Iastography imaging5. Includes imaging or'guidance or biopsy (Super needle)
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDR.H, Office of Device Evaluation (ODE)
(Division Sign Oft)Division of Radiological Health
Office of' In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For Use Page 10 of 24
Chison Medical Imaging Co., Ltd. Q Seiles & 17, 18.19 Diagnostic Ultrasound Systems
System: 06/08/09/0 10, 17/18/19 Diagnostic Uhtrasound Systems
Transducer: DBC1I2L, Micro Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Md fprto
General Specific PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M Doppler Doppler Dopple Doppler Modes Imaging Ote
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
Intra-operative(spedify) ___
Intro-Operi~ve (Neuro) ___ ____
LaparoscopicPediatricSmall Organ"'(Speify)___ ______ ________
Neonatal Cephalic _________
Adull CephalicTrans-rectal _____ _____
Trans-vaginal P P P p p Pp 4.5Tran s-u ret h ral ______
Trans-esoph. (non-Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial) ____
__e__ (Urology p p p p p p p 45
______ ther (Ob/GYN) ___ p_ _ p P P Pp
ICardiac CrI ac A dul ' 1 1 1 -
___________Cardiac Pediatric I____ ____
eripheral Vessel Pe'ripheral vessel I I I I______
N = new indication; P = previously cleared by FDA; E =added under this appendixNote: 1. Conmbined modes are B/M. B+PWD. B/Color M. B/PWD or CWD. B/Color/PWJ) or CWD,BlPower/PWD
2.Small Organ: Breast, testes, thyroid3.3D/4D Imaging Mode4.Elastography imaging5. Includes imaging of guidance or biopsy
Prescription Use >C AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 11 of124
Chison Medical Imaging Co.. Lid. Q Series & i7, i8,19 Diagnostic Ultrasound Systems
System: 06/Q81Q91010, i71i8119 Diagnostic Ultrasound Systems
Transducer: D7C1 OL, Micro Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode of 0 eration ____
General Specific PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M Doppler Doppler Doppler Dopple Modes Imaging Other
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
Intra-operalive(Sped ily) ____
Intra-operative (Neuro) I____ I____
LaparoscopicPediatricSmall Organ"i' (specify)Neonatal CephalicAdult CephalicTran s-recta ITranis-vaginal P P p p p p p 4,5Trans-urethralTransesph (non-
Card.) ____
Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)Other (Urology) P p p p p p p 4.5Other(ObIGYN) P p p p p pp 5
Cdiac lCardiac AdultI________ ICardiac PediatriclPeripheral Vessel jPeripheral vessel I I IN = new indication; P =previously cleared by FDA: E added under this appendixNote: 1. Combined modes are BIM, B+PWD. B/Color M. BIPWD or CWD. B/Color/PWD or CWD.B/P'ower/PWD
2.Small Organ: Breast, testes. thyroid3.30/41) Imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy
Prescription Use X AND/ORk Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 10(k)
Section 1.3 indications For use Page 12 of 24
Chison Medical Imaging Co., Ltd. 0 Series & 17, 18,1if Diagnostic Ultrasound Systems
System: Q6IQOIQO/Q1O, 17/1i8/i9 Diagnostic Ultrasound SystemsTransducer: D7C 1OL-C, Micro Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of Operation _________
General Specific PW CW Color Power Combined Harmonic(T rack I Only) (Tracks I & 3) B M Doppler Doppler DooIr Doppler Modes Imaging Ote
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
Intra-operative(Specify)Intra-operative (Neuro)La pa roscop icPediatricSmall Organ"(S ciry)_______Neonatal Cephalic
AdultI Cephalicrs-rctal
Trans-vaginal N N N N N N N 4,5Trans-urethralTrans-esoph. (non-
Card.)I IMusculo-skeletal(Conventional)
-Musculo-skeletal
(Superficial)Other (Urology) N N N N N N N 4,5
*Other (Ob/GYN) N N N N N N N 5ICardiac Cardiac Adult
Cardiac Pediatric IPe hra VsslPeripheral vessel I I I I_______
N =new indication; P = previously cleared by FDA; 13 added under this appendixNote: 1. Combined modes are B/M. B+PWD. B/Color Mv. B/PWD or CWI). B/Color/PWD or CWD.B/Power/PWD
2.SmalI Organ: Breast, testes, thyroid3.3D/41) Imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy
Predicate transducer (K number): K 10 1236. K 120801
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart 0) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 13 of 24
Chison Medical Imaging Co., Ltd. 0 Series & i7. i8. iS Diagnostic Ultrasound Systems
System: QB/O8IO9/Q1O, i7/0i Diagnostic Ultrasound SystemsTransducer: VSC1OL, Volume Probe
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode of 0teration
General Specific B Pw CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M Doppler Doppler Dopole Doppler Modes Imaging Other_
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
Intra-opcrative(Specify)Intra-operative (Neuro)ILaparoscopic
Small Organ"'SpecifyNeonatal Cephalic
Adult Cephalic
_____
Trans-rectalTrans-vaginal N N IN N N N N 3.4.5Trans-urethral
Trans-esoph. (non-Card.) ____
Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)Other (Urology) N N N N IN N N 510____ ther(Ob/GYN) N N N N N N N 5
Cardiac Cardiac AdultI_______ lCardiac PediatricJPen heral Vessel lPeriphSea vessel I____ I I I I I
N = new indication; P = previously cleared by FDA; E added under this appendixNote: 1. Combined modes are B3/M, 13+P WV, B/Color M, B/PWD or CWD, B/Color/PWD or CWD.B/Power/PWI)
2.SmaII Organ: Breast, testes, thyroid3.3D/4D Imaging Mode4.Elastography imaging5. Includes imaging orguidance or biopsy
Predicate transducer (K number): K 101 236
Prescription Use X AND/OR Over-The-Counter Use ___
(Pant21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 14 of24
Chison Medical Imaging Co., Lid. 0 Series & I7, IS. i9 Diagnostic Ultrasound Systems
System: Q61Q8/Q9/O1O, i7Ii8fS D iagnostic Ultrasound SystemsTransducer: DSC2OL, Micra Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode of 0 nation
SGeneral Specific B M PW OW Color Power Combined Harmonic Other(Track I Only) (Tracks I & 3) B M Doppler Doppler Doppler Doppler Modes Imaging
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal P P P P P p p 4.5
Intra-opcrative(Specify) __________
Intro-operative (Neumo) I I___
Laparoscoi IcPediatric P P P P P P P 4,5Small Organ'" I(Specify) __________
Neonatal Cephalic _________
Adult Cephalic ___ ____ _____
Trans-rectal ____________
Trans-vaginalTrans-urethralTrans-esoph. (non-
Card.) ____
Musculo-skeletal(Conventional)Musculo-skeletal(Superficial) _________ ________
Other (Urology) _________
___________Other (Ob/GYN) ________________
!Cardiac Crdiac AdultP_______ ardiac Pediatric P- P P ____ p p P P 5
lPeripheral Vessel lPeripheral vessel I___ I_____ ___I
N new indication; P =previously cleared by FDA; Ei added under this appendixNote: 1. Combined modes arc D/M, B+PWD. B/Color M. B/PWD orCWI). B/Color/PWD or CWD.B/Powcr/PWD
2.Snmall Organ: Breast. testes, thyroid3.3 DI4D Imaging Mode4.Elastography imaging5. Includes imaging or guidance of biopsy
Prescription Use X AND/OR Over-Thec-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFIR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
section 1.3 indications For Use Page 15 of 24
Chison Medical Imaging Co.. Lid. Q Series & 0,.18, 9 Diagnostic Ulirasound Systems
System: Q61Q81Q9/Q1 0, i7/i81i9 Diagnostic Ultrasound SystemsTransducer: 05C20L-A, Micro Convex Array
Intended Use: Diagnostic Ultrasound imaging or fluid flow analysis ofthe human body as follows:
Cliiceal A ppl)icaltion ____ Modecor Iteration
General Specific11 P W CW Color I 'ooer Combined Ifarm, n ic Othe'r(Track I (ink) (Tracks I & 3) ____ ___ Doppler Doptr lDoppler Doppler Modes Iaingc
Ophthalmic Ophthalmic ___
Fetal Imaging & FetalOther Abdominal N N N ____ N N N N 4.5
Intra-operative(Specdly) ___ ______ ____
I nira-oiperati e (Neuro)LaparoscopicPediatric N N N ____ N N N N 4.5
Smal OrcnL'(Specily) ___ ________ _____
Neonatal CeplialicAdult Cephalic ___ ___ ____ _____
Trans-rectalirans-v'agi nal* Finns-u ret bra IIrans-esoph. (non-Card.) ___ ___ __________
Itiuset: -skeletalI Conventional)NI usculo-skeletal(Superficial) ______ _________
Other (Urology) ________ ____ __________
Other (Ob/GjYN) ______ _________
Cardiac Cardiac AdultCardiac Pediatric N N N _4 N N N N 5
Peripheral Vessel PleripEhrlvesselIIN = newv indication: 1P previously cleared by FDA: 1: = added under this appendix
Note : 1. (\ombi ned modes are HlI. 13+1' WI. li/Color NI. l3/'W I) or CWVD I). i/olor/I' WI or CW P. I3I'owecrll'WI)2.Sniall ( )gan: Brunast. testes. th.\roid3.31)/Il) lImaging Mode-l .Flastograph% imaging5inc ludes ijifleill or, 'uidanice of biopsy
Priedicate tranSducer (K numbecri: K 101236. K 12181
Prescription tise )< AND/OR Over-The-Counter Use ___
(Part 2 1 CFER 801 Subpaii D) (2 1 CER 807 Subpart C)(PLEASE DO0 NOT WRITE BELOWTIIS LINE-CONTINUE ON ANOI If-R PAGE If: Ni-I)ED)
Concurrence of CDRIl1, Office of Device Evaluation -(OD))
(IDivision Sign Ofi)Division of Radiological H ealth
Office of In Vitro IDiagnostic and Radiological I lcaith5 10k ____ _
Section 1.3 indications For use Page 16 of 24
Chison Medical Imaging Co., Lid. Q Series & Mi 18.19g Diagnostic Ultrasound Systems
System: QB/O8/09/Q 10, i7/iB/19 Diagnostic Ultrasound Systems
Transducer: 03C20L, Micro Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode of 0 eration ____
General Specific PW CW Color Power Combined Harmonic(Trak IOnl) (rack I 3) B MOther(Irak IOnl) (Iraks & ) B M DpperE Doper2pprDoper Modes Imaging
Ophthalmic Ophthalmic ____
Fetal Imaging & FetalOther Abdominal N N N _ _ N N N N 4,5
Inin-operative(Specify) _____________
Intre-operative (Neuro) ___ ____
LaparoscopicPediatricSmall Organ"1 (Specify) _________
Neonatal CephalicAdult Cephalic ____
Tran s-rect aTrans-vaginalTran s-u ret hralTrans-esoph. (non-
Card,) ________________
Musculo-skeletal(Conventional) ___________
Musculo-skeletal(Superficial)
Other (Uro ogy) N N N N N N N 5_________Other (ObtGYN) _ _ ___
ICardiac Cardiac Adult N IN N N N N N 5________Cardiac Pediatric N NI N N N N 5
Pecripheral Vessel Peripheral vesselN = new indication; P - previously cleared by FDA; E =added under this appendix
Note: 1. Combined modes are RIM. B+PWD, 8/Color M, BIPWD or CWD. BIColor/PWD or CWD.BPowecrPWD2.Small Organ: Breast, testes, thyroid3.3D1)4D Imaging Mode4.F.lastography imaging5. Includes imaging of' guidance of biopsy
Predicate transducer (K number): K 101236
Prescription Use X AND/ORk Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (2)1 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRHK Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For usre Page 17 of 24
Chison Medical Imaging Co.. Ltd. C Series & 17.,18. i9 Diagnostic Ultrasound Systems
System: 061081Q91Q10, i7/i8/19 Diagnostic Ultrasound SystemsTransducer: DOC 15L, Micro Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application ____ Mode of 0eration _________
General Specific PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks!I & 3) 11 M Doppler Doppler Doppjjr Doppler Modes Imaging Ote
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal P P P P P P P 4.5
Intra-operative(specify)Intra-operative (Neuro) ____
LaparoscopicPediatric N N N N N N N 5
Neonatal Cephal icAdult Cephalic _____
Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-
Card.)Musculo-skeletal(Conventional)Musculo-skeletal(Superficial) _____
Other (Urology)Other(Ob/GYN)
lCardiac ICardiac AdultI_______ ICardiac Pediatric ___ ____
jPeripheral Vessel P1eripheral vesselN - new indication; P = previously cleared by FDA: E =added under this appendixNote: :1 Combined modes arc BIM, B+PWD, B/Color M. B/PWD or CWD. B/Color/PWD or CWD.B/Powcr/PWD
2.Small Organ: Breast, testes, thyroid3.3D14D Imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy
Prescription Use )C AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 SubpartC)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 indications For use Page 18 of 24
Chison Medical Imaging Co., Ltd. C Series & 17. Il8. III Diagnostic Ultrasound Systems
System: O6/O8IQ9/O1O, 17118/iS Diagnostic Ultrasound Systems
Transducer: 0601 5L-A, Micro Convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of thc human body as follows:Clinical Appication ____ Mode of 0peration ____________
General Specific B M PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) M DoppIc DopIcr Doppler Dapple Modes Imaging Ote
Ophthalmic Ophthalmic ___ ____ _____
Fetal Imaging & FetalOther Abdominal N N N N N N N 4.5
Intra-operative(Specify) ____ ____
Intrit-operative (Neuro) I__I__II
Pediatric N N N N IN N N 5SmallI Organ'' (Specil) _________
eoasatal Cephalic _________ ________
dult Ccphalic ____ _____
rans-rectal _____ _____
ran s-u ret hralTrans-esoph. (non-
Card.) _ _ _ _
Musculo-skeletal(Conventional) ____
Musculo-skeletal(Superficial) ___ ____ ____
Other (Urology) _________
__________Other (Ob/GYN) _ ______
ardiac ICardiac Adult ____ _____
I________ ICardiac Pediatric ____ _____
leripheral Vessel IPeripheral vesselN - new indication; P = previously cleared by FDA; E =added under this appendix
Note: 1. Combined modes are B/M. B+PWD. B/Color M. B/PWD or CWD. B/Color/PWD or CWD.B/Powvcr/PWD2.Small Organ: Breast. testes, thyroid3.3D/4D imaging Mode4.Elastography imaging5. Includes imaging ofiguidance or biopsy
Predicate transducer (K number): K 101236. K 120801
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CER 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 19 ot 24
Chison Medical Imaging Co.. Ltd. 0 Series & U, 18,.i9 Diagnostic Ultrasound Systems
System: Q6iQB/QS/Q1O, 17/i5/19 Diagnostic Ultrasound SystemsTransducer: D3P64L, Phased Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application Mode of 0peration _________
General Specific PW CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M Doppler Doppler2p r Doppler! Modes Imaging Ote
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
Intra-operalive(speify) ___ ___
Intra-operative (Neuro)LaparoscopicPediatricSmall Organ'(S-pecify) ___ ____ ____
Neonatal CephalicAdult Cephalic _____
Trans-rectalrrans-vaginalFrans-urethralrrans-esoph. (non-
Card.) __ ___ _ __
Miusculo-skelelal(Conventional) ______ _________
Musculo-skeletal(Superficial) _____
Other (Uology) ____
________Other (Ob/GYN) I_______
CricCardiac Adult P P P P p p Pp 5______________Cardiac PediatricPeriherl VeselPeripheral vessel
N =new indication; P = previously cleared by FDA; E - added under this appendixNote: 1. Combined modes arc RIM, B+PWD. B/Color M. 1/PWD or CWD. B/ColorIPWD or CWD.BlPower/PWD
2.Small Organ: Breast. testes, thyroid3.3D/4D Imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy
Prescription Use >( AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRHK Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Secion 1.3 Indications For Use Page 20 of 24
Chison Medical Imaging Co., Ltd. C Series & 17.,19 i Diagnostic ultrasound Systems
System: 06106109/Q1O, W7/8/9 Diagnostic Ultrasound SystemsTransducer: DSP64L, Phased Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode ol peration _________
General specific l'W CW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) 13 M OtherDplr 2~r oper Mds mgn
Ophthalmic OphthalmicFetal Imaging & FetalOther Abdominal
I ntra-operative(Spec,&)latin-operative (Neuro)I
Lpocoic __________
PediatricSmall Organ" (SpeI~Neonatal Cephalic
Adult Cephalic _________
Trans-rectalTranis-vaginalTrans-urethrnalTrans-esoph. (non-Card.) _____
Musculo-skeletal(Conventi onalI) ___________
Musculo-skeletal(Superficial)Other (Urology) ___ ____
____________Other (Ob/GYN) ____
CardiacCardiac Adult
________ ardiac Peditric P P p P P P P p 5
N =new indication; P = previously cleared by FDA; Ei = added under this appendixNote: 1. Combined modes are B/M. B+PWD. B/Color M. B/PWD or CWD, B/Color/PWD or CWD,I3/Powcr/PWD
2.Small Organ: Breast, testes. thyroid3.3D/4D Imaging Mode4.Elastography imaging5. Includes imaging orguidance of biopsy
Prescription Use )< AND/ORk Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 21 of 24
Chison Medical imaging Co.. Ltd. 0 Series & R.is. 19 Diagnostic Ultrasound Systems
System: O6IO8/091010, 17iMfi Diagnostic Ultrasound Systems
Transducer: D2D1B6L, Pencil Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of 0 eratlon _____ ________
General Specific PW CW Color Power Combined HarmonicOhr(Track I Only) (Tracks I & 3) B M Donnlij 221?n& Doppler Doppler Modes Imaging Ote
Ophthalmic OphthalmicFetallImaging & FetalOther Abdominal
Intra-operalive(Specify)Inlrat-operative (Neuro)LaparoscopicPediatricSmall Organ(peiy ____ ____
Neonatal Cephalic _____
Adult Cephalic ____
Tran s-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-
Card.) ____
Musculo-skeletal(Conventional)Musculo-skeletal(Superficial)O0ther (Urology) _________
_________Oter (Ob/GYN) ______
ICardiac Criac Adutg N ____
___________Criac Pediatric N ____ _____
Perihera Vesel Priperal vesselN = new indication; P - previously cleared by FDA: EB = added under this appendixNote: 1. Combined modes arm B/M. B+PWD. B/Color M. B/PWD or CWD. B/Color/PWD or CWD.B/Powcr/PWD
2.Sniall Organ: Breast. testes, thyroid3.30/41) Imaging Mode4.Elastography imaging5. Includes imaging of guidance or biopsy
Predicate transducer (K number): Kl101236
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CER 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH-, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 10(k)
Section 1.3 Indicationts For Use Page 22 of 24
Chison Medical Imaeging Co.. Ltd. 0 Series & FT. i8. 19 Diagnostic Ultrasound Systems
System: Q6/08/Q9QO,7ri8119 Diagnostic Ultrasound SystemsTransducer: V4C4OL, Volume probe
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:Clinical Application Mode of 0 peratlon _________
General Specific B M PW OW Color Power Combined HarmonicOte(Track I Only) (Tracks I & 3) B M ~ Dopple Dapple~a Dopicr Modes Imaging Ote
Ophthalmic OphthalmicFetal Imaging & Fetal p p p p p p P 3.Other Abdominal P p p p p p p 3,41
Intra-operative(Specifyi) ___
Intra-operative (Neuro) ____
LaparoscopicPediatricSmall Organ'(Secfy ____
Neonatal CephalicAdult Cephatic _____
Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-
Card.)Musculo-skeletal(Conventional) _________
Musculo-skeletal(Superficial) _____
Other (Urology) P p p p p p p______Other (Ob/GYN) ____ P P P P____
Cardiac iCardiac Adult ____
I_____ _ IC ardiac Pediatric _________
jPeripheral Vessel jPeripheral vesse __________
N = new indication; P = previously cleared by FDA; E added under this appendixNote: 1. Combined modes are B/M. B+P Wi. 1/Color M. B/PWD or CWD. B/Color/P Wi or CWD,R/Power/PWD
2.Small Organ: Breast, testes, thyroid3.31)141 Imaging Mode4.Elastography imaging5. Includes imaging of guidance or biopsy
Prescription Use X AND/OR Over-The-Counter Use ___
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Oft)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health5 1 0(k)
Section 1.3 Indications For Use Page 23 of 24
Chison Medical Imaging Co.. Ltd. Q Series & 17,1i8,19 Diagnostic Ultrasound Systems
System: Q6108/09/Q1O, 17/18/i9 Diagnostic Ultrasound SystemsTransducer: V4C4OL-C, Volume Probe
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
I- Clinical Application Mode of 0peration _________
General specific 13 M PW CW Color Power Combined Harmonic Other(Track I Only) (Tracks I & 3) B M oppe Dop Doppler Doppler Modes Imaging
Ophthalmic Ophthalmic ________ ___
Fetal Imaging & Fetal N N N N N N N 3.Other Abdominal N N N N IN N N 3.4
Intra-operative(specify') ___ ____ ___
Intra-operative (Neuro) I____I_
LaparoscopicPediatricSmallI Organ'(pc) __________
Neonatal CephalicAdult Cephalic _________
Tran s-rectal _____
Trans-vaginallTrans-urethralTrans-esoph. (non-
Card.l,___ __ ___ ___
usculo-skeletal(Conventional) _____
Musculo-skeletal(Superficial)Other (Urology) N N N N N N N
______Other (Ob/GYN) N N N N N N N!Cardiac iCardiac Adult 11 1 1
1________ ICardiac PediatricI I
lPeripheral Vessel P1eripheral vessel I I II IN = new indication; P - previously cleared by FDA; E =added under this appendixNote: 1. Combined modes arc B/M. B+PWD. B/Color M. B/PWD or CWD. B/Color/PWD or CWD.B/Powvcr/PWD
2.SmaII Organ: Breast. testes. thyroid3.313/41D Imaging Mode4.Elastography imaging5. Includes imaging of guidance of biopsy
Predicate transducer (K number): K TO01236. K 12080)
Prescription Use >C AND/OR Over-The-Counter Use ___
(Part 2l CPR 80I Subpart D) (21 CFR 8O7SubpartC)(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)Division of Radiological Health
Office of In Vitro Diagnostic and Radiological Health510(k)
Section 1.3 Indications For Use Page 24 of 24